Literature DB >> 14629737

Dermal penetration of fentanyl: inter- and intraindividual variations.

Rikke H Larsen1, Flemming Nielsen, Jens A Sørensen, Jesper B Nielsen.   

Abstract

Fentanyl is a potent synthetic opioid that is increasingly being used in transdermal drug delivery systems. The target organ concentration of a drug administered dermally will depend on the rate of dermal absorption and the systemic elimination. We have studied the intra- and interindividual variation in dermal penetration of fentanyl in an in vitro model (static diffusion cells) with human skin, and compared the absorption of fentanyl from an aqueous solution with absorption from a commercial patch. The intraindividual variation in dermal penetration of fentanyl in aqueous solution was limited (18%) and no differences in penetration characteristics were observed between breast and abdominal skin. The interindividual variation in dermal penetration of fentanyl was extensive, with maximal fluxes ranging from 21-105 ng/cm2/hr following application of an infinite dose of fentanyl to the donor chamber. Use of transdermal drug delivery systems (patches) reduced the inter-individual variation. The permeability coefficients after application of fentanyl in aqueous solution and through patches were identical (0.0011 cm/hr). One person had a higher than average penetration rate following patch application, which may indicate that the human skin and not the patch barrier was the rate-determining factor for the other individuals included in this study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629737     DOI: 10.1046/j.1600-0773.2003.pto930508.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  9 in total

1.  Efficacy of skin wash on dermal absorption: an in vitro study on four model compounds of varying solubility.

Authors:  Jesper Bo Nielsen
Journal:  Int Arch Occup Environ Health       Date:  2010-05-26       Impact factor: 3.015

2.  Comparison of open-flow microperfusion and microdialysis methodologies when sampling topically applied fentanyl and benzoic acid in human dermis ex vivo.

Authors:  R Holmgaard; E Benfeldt; J B Nielsen; C Gatschelhofer; J A Sorensen; C Höfferer; M Bodenlenz; T R Pieber; F Sinner
Journal:  Pharm Res       Date:  2012-03-15       Impact factor: 4.200

3.  Nonlinear quantitative structure-property relationship modeling of skin permeation coefficient.

Authors:  Brian J Neely; Sundararajan V Madihally; Robert L Robinson; Khaled A M Gasem
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

Review 4.  Transdermal fentanyl: pharmacology and toxicology.

Authors:  Lewis Nelson; Robert Schwaner
Journal:  J Med Toxicol       Date:  2009-12

Review 5.  Use of transdermal drug formulations in the elderly.

Authors:  Laure-Zoé Kaestli; Anne-Florence Wasilewski-Rasca; Pascal Bonnabry; Nicole Vogt-Ferrier
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Effect of Frozen Human Epidermis Storage Duration and Cryoprotectant on Barrier Function Using Two Model Compounds.

Authors:  Ana M Barbero; H Frederick Frasch
Journal:  Skin Pharmacol Physiol       Date:  2015-11-26       Impact factor: 3.479

7.  Efficacy of fentanyl transdermal patch in pain control after lower third molar surgery: A preliminary study.

Authors:  V-S Todorovic; M Vasovic; M Andric; L Todorovic; V Kokovic
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-09-01

8.  Is the transdermal fentanyl patch an efficient way to achieve acute postoperative pain control?: A randomized controlled trial.

Authors:  Ji Su Jang; Sung Mi Hwang; Youngsuk Kwon; Hyunjin Tark; Young Joon Kim; Byoung Yoon Ryu; Jae Jun Lee
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

9.  A new drug release method in early development of transdermal drug delivery systems.

Authors:  Bing Cai; Karin Söderkvist; Håkan Engqvist; Susanne Bredenberg
Journal:  Pain Res Treat       Date:  2012-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.